EVERY SECOND COUNTS!

Serial Number 90327275
Registration 6506386
700

Registration Progress

Application Filed
Nov 18, 2020
Under Examination
Approved for Publication
Jul 20, 2021
Published for Opposition
Jul 20, 2021
Registered
Oct 5, 2021

Basic Information

Serial Number
90327275
Registration Number
6506386
Filing Date
November 18, 2020
Registration Date
October 5, 2021
Published for Opposition
July 20, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Oct 5, 2021
Registration
Registered
Classes
042

Rights Holder

KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC.

83
Address
THIRD FLOOR, 23 OLD BOND STREET
LONDON W1S 4PZ
GB

Ownership History

Kiniksa Pharmaceuticals, Ltd.

Original Applicant
03
Hamilton HM 11 BM

Kiniksa Pharmaceuticals, Ltd.

Owner at Publication
03
Hamilton HM 11 BM

Kiniksa Pharmaceuticals, Ltd.

Original Registrant
03
Hamilton HM 11 BM

KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC.

New Owner After Registration #1
83
LONDON GB

Legal Representation

Attorney
Maury M. Tepper, III

USPTO Deadlines

Next Renewal Deadline
819 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-10-05)
Due Date
October 05, 2027
Grace Period Ends
April 05, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

15 events
Date Code Type Description
Apr 11, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 5, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER
Jul 20, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 20, 2021 PUBO A PUBLISHED FOR OPPOSITION
Jun 30, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 17, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
May 24, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
May 23, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 23, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 28, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 28, 2021 GNRT F NON-FINAL ACTION E-MAILED
Apr 28, 2021 CNRT R NON-FINAL ACTION WRITTEN
Apr 21, 2021 DOCK D ASSIGNED TO EXAMINER
Jan 21, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 21, 2020 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 042
Pharmaceutical research and development; Providing medical and scientific research information in the field of clinical trials
First Use Anywhere: Sep 30, 2017
First Use in Commerce: Sep 30, 2017

Classification

International Classes
042